Verucerfont

Magaca Kiimikada:

(S) -3- (4-methoxy-2-methylphenyl) -2,5-dimethyl-N- (1- (3-methyl-1,2,4-oxadiazol-5-yl) propyl) pyrazolo [1, 5-a]pyrimidin-7-aamin

Koodhka dhoola cadeynta:

CC[C@H](NC1=CC(C)=NC2=C(C3=CC=C(OC)C=C3C)C(C)=NN12)C4=NC(C)=NO4

Koodhka InChi:

InChi=1S/C22H26N6O2/c1-7-18(22-24-15(5)27-30-22)25-19-11-13(3)23-21-20(14) (4)26-28(19)21)17-9-8-16(29-6)10-12(17)2/h8-11,18,25H,7H2,1-6H3/t18-/m0/ s1

Furaha InChi:

VKHVAUKFLBBZFJ-SFHVURJKSA-N

Ereyga muhiimka ah:

Verucerfont, GSK561679, GSK 561679, GSK-561679, NBI77860, NBI 77860, NBI-77860, 885220-61-1

Xalka:Ku milmay DMSO

Kaydinta:0 - 4°C muddo gaaban (maalmo ilaa toddobaadyo), ama -20°C muddo dheer (bilo).

Sharaxaad:

"Verucerfont, oo sidoo kale loo yaqaan GSK561679 iyo NBI77860, waa CRF-1 antagonist. Verucerfont waxay xannibaysaa soo-dhoweynta CRH-1, sidaas darteed waxay yareysaa sii-deynta ACTH ka dib walaaca daba-dheeraada. arrin ka mid ah horumarinta khamriga iyo soo noqoshada soo kabashada khamriga Waxay muujisay natiijooyin rajo leh daraasado xayawaan ah laakiin aan lagu tijaabin dadka.

Ujeedka: CRF-1